Show simple item record

dc.contributor.authorCusso, Lorena 
dc.contributor.authorDesco, Manuel 
dc.date.accessioned2018-11-05T11:58:19Z
dc.date.available2018-11-05T11:58:19Z
dc.date.issued2018
dc.identifierISI:000447638200058
dc.identifier.citationPLoS One. 2018; 13(10):e0205610
dc.identifier.issn1932-6203
dc.identifier.urihttp://hdl.handle.net/20.500.12105/6568
dc.description.abstractIntroduction Retention of 2-deoxy-2-[F-18]fluoro-D-glucose F-18-FDG in the bladder causes more problems in small animal research than in human research owing to the smaller size of the subject. Catheterization has been proposed to reduce bladder spillover both in human studies and in small animal research. Noninvasive alternatives such as hydration plus furosemide also seem to be a promising pre-imaging strategy for decreasing bladder spillover. Our main goal was to measure the effects of the combination of furosemide and hydration for reducing bladder signal directly on mouse bowel F-18-FDG-PET images. Methods Nine mice were divided into two groups: the control group (C, n = 4) and the treatment group (n = 5). The clearance protocol combines hyperhydration and a single furosemide dose during the F-18-FDG uptake period. Two images were acquired on different days in treated mice to evaluate two different furosemide doses (low dose, LD, 3.5 mg/kg; and high dose, HD, 7 mg/kg). A region of interest was drawn on each computed tomography image (bladder, kidneys, liver, muscle, and bone marrow). To quantify bladder spillover, two different areas of the colon were selected. Results A remarkable reduction in bladder spillover was achieved on F-18-FDG-PET in both groups. Our imaging findings were quantified, and both furosemide doses induced a decrease in mean standard uptake values (SUVmean) compared with the controls (LD 1.46 +/- 0.54 and HD 1.05 +/- 0.29; controls: 8.90 +/- 3.4 [p-value < 0.05]). Conclusion We validated a non-invasive, easy, and harmless pre-imaging alternative for decreasing F-18-FDG bladder spillover. Our study shows the effect of furosemide on bladder spillover directly on F-18-FDG-PET images by measuring SUVmean in the bladder, colon, liver, muscle, and bone marrow.
dc.description.sponsorshipThis work was partially supported by Spanish Ministerio de Ciencia, Innovacion y Universidades (ISCIII grant PIE16/00055) and co-financed by ERDF (FEDER) Funds from the European Commission, ``A way of making Europe´´. It was also supported by the Comunidad de Madrid (S2017/BMD-3867 RENIM-CM) (MD) and cofunded with European structural and investment funds. The CNIC is supported by the Ministerio de Ciencia, Innovacion y Universidades and the Pro CNIC Foundation and is a Severo Ochoa Center of Excellence (SEV-2015-0505).
dc.language.isoeng
dc.publisherPublic Library of Science
dc.relation.isversionofPublisher's version
dc.rights.urihttp://creativecommons.org/licenses/by/4.0/*
dc.subjectMALIGNANCIES
dc.subjectINFLAMMATION
dc.subjectFUROSEMIDE
dc.subjectONCOLOGY
dc.titleSuppression of F-18-FDG signal in the bladder on small animal PET-CT
dc.typeArtículo
dc.rights.licenseAtribución 4.0 Internacional*
dc.identifier.pubmedID30332442
dc.format.volume13
dc.identifier.doi10.1371/journal.pone.0205610
dc.contributor.funderInstituto de Salud Carlos III - ISCIII
dc.contributor.funderEuropean Regional Development Fund (ERDF/FEDER)
dc.contributor.funderComunidad de Madrid
dc.contributor.funderMinisterio de Ciencia, Innovacion y Universidades (España)
dc.contributor.funderFundación ProCNIC
dc.description.peerreviewed
dc.relation.publisherversionhttps://doi.org/10.1371/journal.pone.0205610
dc.identifier.journalPLoS ONE
dc.repisalud.orgCNICCNIC::Unidades técnicas::Imagen Avanzada
dc.repisalud.institucionCNIC
dc.rights.accessRightsinfo:eu-repo/semantics/openAccesses_ES


Files in this item

Acceso Abierto
Thumbnail
Acceso Abierto
Thumbnail

This item appears in the following Collection(s)

Show simple item record

Atribución 4.0 Internacional
This item is licensed under a: Atribución 4.0 Internacional